OC000459
OC000459 is a pharmaceutical drug with 9 clinical trials. Historical success rate of 100.0%.
Success Metrics
Based on 9 completed trials
Phase Distribution
Phase Distribution
2
Early Stage
7
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 2Trial Status & Enrollment
100.0%
9 of 9 finished
0.0%
0 ended early
0
trials recruiting
9
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Effect of OC000459 on Eosinophilic Airway Inflammation in Severe Asthma
Effect of OC000459 on Moderate to Severe Atopic Dermatitis
Evaluation of Metabolic Profile of OC000459
Proof of Concept Study of OC000459 in Eosinophilic Esophagitis
A Study Of The Effects Of OC000459 In Subjects Known To Suffer From Grass Pollen Induced Allergic Rhinitis
Clinical Trials (9)
Effect of OC000459 on Eosinophilic Airway Inflammation in Severe Asthma
Effect of OC000459 on Moderate to Severe Atopic Dermatitis
Evaluation of Metabolic Profile of OC000459
Proof of Concept Study of OC000459 in Eosinophilic Esophagitis
A Study Of The Effects Of OC000459 In Subjects Known To Suffer From Grass Pollen Induced Allergic Rhinitis
Study to Evaluate the Potential for Interaction Between OC000459 and CYP 450 3A4
Safety and Efficacy Study of OC000459 Dosed Twice Daily for 28 Days in Asthmatic Subjects
OC000459 Bronchial Allergen Challenge
OC000459 Dose Finding Study in Hay Fever Sufferers.
All 9 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 9